Citations

Clear

1446 citation(s) found for "Howard, F".

Smoking and prostate cancer in a multi‐ethnic sample
Murphy, Adam B. , Akereyeni, Folasade, Nyame, Yaw A. , Guy, Mignonne C. , Martin, Iman K. , Hollowell, Courtney M.P. , Walker, Kelly, Ahaghotu, Chiledum, Kittles, Rick A.

Mayo Clinic

The Prostate | July 3, 2013 | Volume: 73 | Issue: 14 | Pages: 1518-1528

10.1002/pros.22699 | PMID 23824512 Get It

ABSTRACTBACKGROUNDProstate cancer (PCa) and smoking‐related morbidity disproportionately burdens African American (AA) men. Smoking is associated with high‐grade PCa and incidence, but few studies have focused on AA men. This study aims to determine the effect of tobacco‐use on odds of PCa and of high‐grade PCa in a population of predominantly AA men.METHODSThis is a cross‐sectional study evaluating smoking and PCa status in men with incident PCa and screened healthy controls. Altogether, 1,085 men (527 cases and 558 controls), age ≥ 40 years were enrolled through outpatient urology clinics in two US cities from 2001 to 2012. Validated questionnaires were used to gather clinical and socioeconomic data.RESULTSThe cases and controls were predominantly AA (79.9% and 71.3%, respectively, P = 0.01). AA men smoked more frequently (53.4% vs. 47.9%, P < 0.001) and quit less frequently than European American (EA) men (31.5% vs. 40.4%, P = 0.01). AA heavy smokers had increased odds of PCa diagnosis (OR 2.57, 95% CI 1.09, 6.10) and high‐grade cancer (OR 1.89, 95% CI 1.03, 3.48) relative to never smokers and light smokers. Among AAs, heavy smokers had lower odds of being in the low risk stratification in the National Comprehensive Cancer Network guidelines. AA former smokers had a trend for increased odds of high‐grade cancer compared to never smokers. The associations between smokings, cancer diagnosis and cancer grade did not reach statistical significance in EA men.CONCLUSIONWe found ethnic differences in smoking behavior. Heavy smoking is associated with increased odds of PCa and of higher Gleason grade in AA men. Prostate 73: 1518–1528, 2013. © 2013 Wiley Periodicals, Inc.
Risk-stratified imputation in survival analysis
Kennedy, Richard , Adragni, Kofi P. , Tiwari, Hemant K., Voeks, Jenifer H. , Brott, Thomas G. , Howard, George , Kennedy, Richard E , Howard, George

Mayo Clinic

Clinical Trials | July 2, 2013 | Volume: 10 | Issue: 4 | Pages: 530-539

10.1177/1740774513493150 | PMID 23818434 Get It

Background Censoring that is dependent on covariates associated with survival can arise in randomized trials due to changes in recruitment and eligibility criteria to minimize withdrawals, potentially leading to biased treatment effect estimates. Imputation approaches have been proposed to address censoring in survival analysis; while these approaches may provide unbiased estimates of treatment effects, imputation of a large number of outcomes may over- or underestimate the associated variance based on the imputation pool selected. Purpose We propose an improved method, risk-stratified imputation, as an alternative to address withdrawal related to the risk of events in the context of time-to-event analyses. Methods Our algorithm performs imputation from a pool of replacement subjects with similar values of both treatment and covariate(s) of interest, that is, from a risk-stratified sample. This stratification prior to imputation addresses the requirement of time-to-event analysis that censored observations are representative of all other observations in the risk group with similar exposure variables. We compared our risk-stratified imputation to case deletion and bootstrap imputation in a simulated dataset in which the covariate of interest (study withdrawal) was related to treatment. A motivating example from a recent clinical trial is also presented to demonstrate the utility of our method. Results In our simulations, risk-stratified imputation gives estimates of treatment effect comparable to bootstrap and auxiliary variable imputation while avoiding inaccuracies of the latter two in estimating the associated variance. Similar results were obtained in analysis of clinical trial data. Limitations Risk-stratified imputation has little advantage over other imputation methods when covariates of interest are not related to treatment. Risk-stratified imputation is intended for categorical covariates and may be sensitive to the width of the matching window if continuous covariates are used. Conclusions The use of the risk-stratified imputation should facilitate the analysis of many clinical trials, in which one group has a higher withdrawal rate that is related to treatment.
ADAM17 Controls Endochondral Ossification by Regulating Terminal Differentiation of Chondrocytes
Hall, K. , Hill, Daniel, Otero, Miguel , Plumb, Darren A., Froemel, Dara, Dragomir, C., Maretzky, Thorsten , Boskey, Adele L. , Selleri, Licia , Blobel, Carl , Crawford, Howard C. , Goldring, Mary B.

Mayo Clinic

Molecular and Cellular Biology | June 4, 2013 | Volume: 33 | Issue: 16 | Pages: 3077-3090

10.1128/mcb.00291-13 | PMID 23732913 Get It

The Reverend: Waiting for a Miracle
Howard, B, Shannon, Robert P.

Mayo Clinic

Journal of Palliative Medicine | May 19, 2013 | Volume: 16 | Issue: 7 | Pages: 801-802

10.1089/jpm.2012.0459 | PMID 23683129 Get It

Capturing the aversive state of cephalic pain preclinically
Felice, Milena De , Eyde, Nathan, Ossipov, Michael H. , Fields, Howard L. , Dodick, David W. , Dussor, Gregory O. , Porreca, Frank

Mayo Clinic

Annals of Neurology | May 18, 2013 | Volume: 74 | Issue: 2 | Pages: 257-265

10.1002/ana.23922 | PMID 23686557 Get It

Objective Preclinical evaluation of headache by behavioral assessment of reward from pain relief. Methods Inflammatory mediators (IMs) or control solution were applied to the rat dura mater to elicit a presumed state of cephalic pain. Hind paw incision was used in separate groups of animals to model noncephalic postsurgical pain. Drugs were given systemically or microinjected within the rostral ventromedial medulla (RVM), nucleus accumbens (NAc), or rostral anterior cingulate cortex (rACC). Peripheral nerve block was produced at the level of the popliteal fossa, and behavior was assessed using evoked sensory stimuli or conditioned place preference (CPP). Immunohistochemistry and brain microdialysis measurements were performed. Results Dural IMs produced long‐lasting generalized cutaneous allodynia. RVM lidocaine produced CPP, increased NAc c‐Fos, and dopamine release selectively in rats receiving dural IMs; CPP was blocked by intra‐NAc α‐flupenthixol, a dopaminergic antagonist. Intravenous α‐calcitonin gene‐related peptide (αCGRP) (8–37) produced CPP and elicited NAc dopamine release selectively in rats treated with dural IMs. Prior lesion of the rACC or treatment with systemic sumatriptan or αCGRP (8–37) abolished RVM lidocaine‐induced CPP in IM‐treated rats. Sumatriptan treatment blocked NAc dopamine release in IM‐treated rats receiving RVM lidocaine. Systemic sumatriptan did not alter pain relief‐induced CPP in rats with incisional injury. Interpretation Cephalic pain was unmasked in rats by assessment of motivated behavior to seek relief. Relief of pain activates the dopaminergic reward pathway to elicit negative reinforcement of behavior. Medications clinically effective for migraine headache selectively elicit relief of ongoing cephalic, but not postsurgical, noncephalic pain. These studies provide a platform for exploring migraine pathophysiology and for the discovery of new headache therapies. Ann Neurol 2013;74:257–265
Ectopic fat and adipokines in metabolically benign overweight/obese women: The kronos early estrogen prevention study
Ogorodnikova, Alexandra D., McGinn, Aileen P., Zeb, Irfan , Budoff, Matthew J. , Harman, S. Mitchell , Miller, Virginia M. , Hodis, Howard N., Merriam, George R., Cedars, Marcelle I. , Taylor, Hugh S. , Løbo, Rogerio A. , Wildman, Rachel P., Khan, Unab Inayat , Brinton, Eliot A. , Manson, JoAnn E. , Naftolin, Frederick , Santoro, Nanette F. , Budoff, Matthew

Mayo Clinic

Obesity | May 13, 2013 | Volume: 21 | Issue: 8 | Pages: 1726-1733

10.1002/oby.20200 | PMID 23670850 Get It

ObjectiveIt is unclear why despite a comparable cardiometabolic risk profile, “metabolically benign” overweight/obese individuals show an elevated risk of cardiovascular disease compared to normal weight individuals.Design and MethodsIn cross‐sectional analyses, we compared levels of ectopic fat (epicardial, pericardial, and hepatic fat) and adipokines (leptin, soluble leptin receptor, and high molecular weight [HMW] adiponectin) among metabolically benign (MBO) and at‐risk overweight/obese (ARO), and metabolically benign normal weight (MBNW) women, screened for the Kronos Early Estrogen Prevention Study. We defined “metabolically benign” with ≤ 1, and “at‐risk” with ≥2 components of the metabolic syndrome.ResultsCompared to MBO women, ARO women had significantly elevated odds of being in the top tertile of epicardial fat (OR: 1.76, 95% CI: 1.04‐2.99), hepatic fat (OR: 1.90, 95% CI:1.12‐3.24) and leptin (OR: 2.15, 95% CI: 1.23‐3.76), and the bottom tertile of HMW‐adiponectin (OR: 2.90, 95% CI: 1.62‐5.19). Compared to MBNW women, MBO women had significantly higher odds of being in the top tertile of epicardial fat (OR: 5.17, 95% CI: 3.22‐8.29), pericardial fat (OR: 9.27, 95% CI: 5.52‐15.56) and hepatic fat (OR: 2.72, 95% CI: 1.77‐4.19) and the bottom tertile of HMW adiponectin levels (OR: 2.51, 95% CI: 1.60‐3.94).ConclusionsLevels of ectopic fat and the adverse adipokine profile increase on a continuum of BMI, suggesting that the metabolically benign phenotype may be a transient state.
Blood Transfusion Therapy in Behçet's Disease
O’Duffy, J. Desmond, TASWELL, HOWARD F., TASWELL, HOWARD F.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 80 | Issue: 2 | Pages: 279-279

10.7326/0003-4819-80-2-279_2 | PMID 4811808 Get It

Malignant Melanoma with Delayed Metastatic Growths
Wilbur, Dwight L., HARTMAN, HOWARD R.

Mayo Clinic

Annals of Internal Medicine | April 12, 2013 | Volume: 5 | Issue: 2 | Pages: 201-211

10.7326/0003-4819-5-2-201 Get It

The Effect of Cholecystectomy On Gastric Acidity
HARTMAN, HOWARD R., Rivers, Andrew B.

Mayo Clinic

Annals of Internal Medicine | April 11, 2013 | Volume: 1 | Issue: 8 | Pages: 558-562

10.7326/0003-4819-1-8-558 Get It